Zealand Pharma A/s
(OTC) ZLDPF
Zealand Pharma A/s Financials at a Glance
Market Cap
$3.16B
Revenue (TTM)
DKK 9.24B
Net Income (TTM)
DKK 6.40B
EPS (TTM)
$13.43
P/E Ratio
3.25
Dividend
$0.00
Beta (Volatility)
0.37 (Low)
Dividend
$0.00
Beta (Volatility)
0.37 (Low)
Price
$44.70
Volume
1
Open
$44.70
Price
$44.70
Volume
1
Open
$44.70
Previous Close
$44.70
Daily Range
$44.70 - $44.70
52-Week Range
$35.93 - $83.12
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
0.37 (Low)
Price
$44.70
Volume
1
Open
$44.70
Previous Close
$44.70
Daily Range
$44.70 - $44.70
52-Week Range
$35.93 - $83.12
Estimated Earnings Date
Aug 13, 2026
ZLDPF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Zealand Pharma A/s
Industry
Biotechnology
Sector
Health CareEmployees
544
CEO
Adam Sinding Steensberg, MD, MBA
Website
www.zealandpharma.comHeadquarters
Copenhagen, 2860, DK
ZLDPF Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
74%
Net Income Margin
69%
Return on Equity
56%
Return on Capital
46%
Return on Assets
42%
Earnings Yield
30.77%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.16B
Shares Outstanding
70.66M
Volume
1
Avg. Volume
1.29K
Financials (TTM)
Gross Profit
DKK 9.17B
Operating Income
DKK 7.14B
EBITDA
DKK 7.17B
Operating Cash Flow
DKK 6.52B
Capital Expenditure
-DKK 33.29M
Free Cash Flow
DKK 6.48B
Cash & ST Invst.
DKK 15.07B
Total Debt
DKK 484.88M
Zealand Pharma A/s Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
DKK 34.04M
+320.6%
Gross Profit
DKK 24.02M
+212.5%
Gross Margin
70.59%
N/A
Market Cap
$3.16B
N/A
Market Cap/Employee
$8.20M
N/A
Employees
385
N/A
Net Income
-DKK 394.41M
-17.6%
EBITDA
-DKK 529.55M
-63.9%
Quarterly Fundamentals
Total Cash
DKK 14.48B
+69.5%
Total Debt
DKK 414.43M
+5.0%
Accounts Receivable
DKK 239.25M
+59.6%
Inventory
DKK 0.00
-100.0%
Long Term Debt
DKK 385.40M
+1.9%
Short Term Debt
DKK 29.03M
+76.5%
Return on Assets
41.80%
N/A
Return on Invested Capital
45.83%
N/A
Free Cash Flow
-DKK 682.71M
-34.0%
Operating Cash Flow
-DKK 672.70M
-34.3%